Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ [Phase 3]
A Phase 3 trial evaluated how long anti-HBs antibodies persist in uraemic patients vaccinated with Henogen's HBV vaccine, Fendrix. The study…
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) [Phase 4]
This Phase 4 long-term follow-up study evaluated safety and durability of Hepatitis B vaccination in newborns born to mothers positive for H…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B during gesta…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) [Phase 3]
Phase 3 completed clinical trial update for a Merck hepatitis B vaccine booster (V232-058); results were posted on 2009-10-12.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B [Phase 4]
Phase 4 trial evaluating 10 mg adefovir dipivoxil in Chinese patients with HBeAg-negative chronic hepatitis B has been completed and results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients [Phase 4]
Phase 4 trial update assessing adefovir dipivoxil in Chinese patients with compensated chronic hepatitis B; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines [NA]
A clinical trial update evaluating the immune response to a Hepatitis B vaccine booster in youths who completed neonatal Hepatitis B vaccina…
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine [Phase 4]
Phase 4 results show safety and immunogenicity of a booster dose of GlaxoSmithKline's hepatitis B vaccine, Engerix-B. The study assesses the…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. [NA]
The document is a clinical trial update on the safety and antiviral study of ACH-126, 443 (Beta-L-Fd4C) in adults with chronic hepatitis B. …
-
CLINICAL_TRIALS research · 2009-08-17Clinical Trial Update: TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 clinical trial update comparing transarterial chemoembolization (TACE) with Adefovir versus TACE alone in patients with HBV-relate…
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years [Phase 3]
Phase 3 long-term follow-up study comparing two formulations of a combined hepatitis A/B vaccine in adolescents (ages 12-15); results coveri…
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]
Phase 4 study of a new formulation of the DTPa-HBV-IPV/Hib vaccine as a booster in children aged 18-23 months; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
A completed trial evaluated whether transcatheter arterial chemoembolization influences hepatitis B viral replication in patients with hepat…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients [Phase 3]
Phase 3 clinical trial update showing results for Adefovir Dipivoxil in compensated chronic hepatitis B, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; s…
-
EMA withdrawal · 2009-07-29EMA Expired: Procomvax (polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC;outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B);adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae)) — Sanofi Pasteur MSD, SNC
The EMA indicates that Procomvax, a combination vaccine for hepatitis B and meningitis Haemophilus influenzae type b, has expired (product s…
-
FDA label_change · 2009-07-16FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Baraclude (entecavir) by E.R. Squibb & Sons, L.L.C. This action updates the labeling for chr…
-
FDA label_change · 2009-07-16FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., reflecting an update to the produ…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) [Phase 3]
A Phase 3 trial of a modified-process Hib/Hep B vaccine in infants has completed, with results posted in July 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060) [Phase 3]
A Phase 3 trial of a Hepatitis B vaccine in predialysis and dialysis patients completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine [Phase 4]
Phase 4 trial update evaluating a challenge dose of Engerix-B in individuals previously vaccinated against Hepatitis B; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil [Phase 2]
Phase 2 trial evaluating treatment of persistent viremia in chronic hepatitis B patients already receiving adefovir dipivoxil.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase IV study evaluating interchangeability of a liquid pentavalent combination vaccine for diphtheria, tetanus, pertussis, hepatitis B, an…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase 4 safety and immunogenicity assessment of a liquid pentavalent DTP-HepB-Hib vaccine completed.